BP
Publicaties op Oncologisch.com
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall surv...
ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvan...
OS met dostarlimab plus carboplatine-paclitaxel bij endometriumcarcinoom: RUBY OS